Hong Kong SAR, China: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Hong Kong SAR, China

The Hong Kong prophylactic medicaments containing insulin market shrank to $X in 2022, approximately mirroring the previous year. In general, the total consumption indicated a temperate increase from 2012 to 2022: its value increased at an average annual rate of +3.5% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by +2.0% against 2020 indices. Over the period under review, the market attained the peak level at $X in 2018; however, from 2019 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Hong Kong SAR, China

In value terms, prophylactic medicaments containing insulin production contracted slightly to $X in 2022 estimated in export price. Over the period under review, the total production indicated notable growth from 2012 to 2022: its value increased at an average annual rate of +3.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production increased by +1.8% against 2020 indices. The pace of growth was the most pronounced in 2017 when the production volume increased by 27%. Prophylactic medicaments containing insulin production peaked at $X in 2018; however, from 2019 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Hong Kong SAR, China

In 2022, after five years of growth, there was decline in shipments abroad of medicaments containing insulin but not antibiotics in measured doses, when their volume decreased by -3% to X tons. In general, exports, however, recorded a strong increase. The most prominent rate of growth was recorded in 2017 with an increase of 108%. Over the period under review, the exports hit record highs at X tons in 2021, and then dropped in the following year.

In value terms, prophylactic medicaments containing insulin exports shrank to $X in 2022. Over the period under review, exports, however, recorded a strong increase. The growth pace was the most rapid in 2017 with an increase of 130%. The exports peaked at $X in 2021, and then contracted in the following year.

Exports by Country

Macao SAR (X tons) was the main destination for prophylactic medicaments containing insulin exports from Hong Kong SAR, accounting for a approx. 100% share of total exports.

From 2012 to 2022, the average annual growth rate of volume to Macao SAR stood at +11.7%.

In value terms, Macao SAR ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Hong Kong SAR.

From 2012 to 2022, the average annual rate of growth in terms of value to Macao SAR amounted to +13.5%.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, falling by -10.6% against the previous year. Overall, export price indicated a modest expansion from 2012 to 2022: its price increased at an average annual rate of +1.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin export price decreased by -19.6% against 2020 indices. The most prominent rate of growth was recorded in 2018 when the average export price increased by 23% against the previous year. Over the period under review, the average export prices reached the maximum at $X per ton in 2020; however, from 2021 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Macao SAR.

From 2012 to 2022, the rate of growth in terms of prices for Macao SAR amounted to +1.6% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Hong Kong SAR, China

Prophylactic medicaments containing insulin imports into Hong Kong SAR surged to X tons in 2022, jumping by 33% against 2021. Overall, imports continue to indicate a remarkable increase. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. Over the period under review, imports posted a resilient increase. The most prominent rate of growth was recorded in 2014 when imports increased by 26%. Over the period under review, imports reached the maximum in 2022 and are likely to see gradual growth in the near future.

Imports by Country

Singapore (X tons), Brazil (X tons) and France (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Hong Kong SAR, together accounting for 75% of total imports.

From 2012 to 2022, the biggest increases were recorded for Brazil (with a CAGR of +49.3%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Hong Kong SAR were Singapore ($X), Brazil ($X) and France ($X), together accounting for 75% of total imports.

Brazil, with a CAGR of +46.0%, recorded the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, reducing by -11.7% against the previous year. In general, the import price recorded a noticeable contraction. The pace of growth was the most pronounced in 2018 an increase of 15% against the previous year. As a result, import price reached the peak level of $X per ton. From 2019 to 2022, the average import prices failed to regain momentum.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the highest price was recorded for prices from Singapore ($X per ton) and Brazil ($X per ton), while the price for France ($X per ton) and Denmark ($X per ton) were amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (-1.1%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :